{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:38:01Z","timestamp":1792827481746,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"DOI":"10.1007\/s11095-026-04219-9","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T18:25:13Z","timestamp":1792779913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Integrated Framework for Evaluating Poor Biorelevant Stability during First-in-Human (FIH) Development"],"prefix":"10.1007","author":[{"given":"Prashant","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Karmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd A.","family":"Bruenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Coppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Wegesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Basra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronya","family":"Primack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Faraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Nag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Akrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wale","family":"Rufai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Almon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Crossley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike J.","family":"Frohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Pickrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heemal","family":"Dhanjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaika","family":"Doerfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Greenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4399-2452","authenticated-orcid":false,"given":"Darren L.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"issue":"2","key":"4219_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1208\/s12248-019-0402-2","volume":"22","author":"W Yang","year":"2020","unstructured":"Yang W, Gadgil P, Krishnamurthy VR, Landis M, Mallick P, Patel D, et al. The evolving druggability and developability space: chemically modified new modalities and emerging small molecules. AAPS J. 2020;22(2):21.","journal-title":"AAPS J"},{"key":"4219_CR2","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH M9: biopharmaceutics classification system-based biowaivers. 2019, (2019)."},{"key":"4219_CR3","unstructured":"ICH. Impurities in new drug substances Q3A (R2). 2006."},{"key":"4219_CR4","unstructured":"ICH. Impurities in new drug products Q3B(R2). 2006."},{"key":"4219_CR5","unstructured":"ICH M10 \u2014 Bioanalytical method validation and study sample analysis."},{"key":"4219_CR6","unstructured":"FDA. International Council for Harmonisation (ICH). M7(R2): assessment and control of DNA reactive (Mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. Step 4 version, adopted 3 April 2023. 2023."},{"key":"4219_CR7","unstructured":"International Council for Harmonisation (ICH). ICH M7(R2) questions and answers. Adopted 24 May 2022."},{"key":"4219_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104807","volume":"118","author":"C Hasselgren","year":"2020","unstructured":"Hasselgren C, Bercu J, Cayley A, Cross K, Glowienke S, Kruhlak N, et al. Management of pharmaceutical ICH M7 (Q)SAR predictions - the impact of model updates. Regul Toxicol Pharmacol. 2020;118:104807.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"4219_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/minf.201200081","volume":"32","author":"R Saiakhov","year":"2013","unstructured":"Saiakhov R, Chakravarti S, Klopman G. Effectiveness of CASE ultra expert system in evaluating adverse effects of drugs. Mol Inform. 2013;32(1):87\u201397.","journal-title":"Mol Inform"},{"issue":"1","key":"4219_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0378-5173(88)90057-9","volume":"43","author":"PK Gupta","year":"1988","unstructured":"Gupta PK, Robinson JR. Gastric emptying of liquids in the fasted dog. Int J Pharm. 1988;43(1):45\u201352.","journal-title":"Int J Pharm"},{"issue":"2","key":"4219_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0034-5288(18)32342-7","volume":"33","author":"RP Happ\u00e9","year":"1982","unstructured":"Happ\u00e9 RP, De Bruijne JJ. Pentagastrin stimulated gastric secretion in the dog (orogastric aspiration technique). Res Vet Sci. 1982;33(2):232\u20139.","journal-title":"Res Vet Sci"},{"issue":"1","key":"4219_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.14712\/23362936.2019.5","volume":"120","author":"M \u0160\u00edma","year":"2019","unstructured":"\u0160\u00edma M, Kutinov\u00e1-Canov\u00e1 N, Ry\u0161\u00e1nek P, Ho\u0159\u00ednkov\u00e1 J, Mo\u0161ko\u0159ov\u00e1 D, Slana\u0159 O. Gastric pH in rats: key determinant for preclinical evaluation of pH-dependent oral drug absorption. Prague Med Rep. 2019;120(1):5\u20139.","journal-title":"Prague Med Rep"},{"issue":"7","key":"4219_CR13","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1002\/jps.22486","volume":"100","author":"RM Fancher","year":"2011","unstructured":"Fancher RM, Zhang H, Sleczka B, Derbin G, Rockar R, Marathe P. Development of a canine model to enable the preclinical assessment of pH-dependent absorption of test compounds. J Pharm Sci. 2011;100(7):2979\u201388.","journal-title":"J Pharm Sci"},{"issue":"2","key":"4219_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0939-6411(99)00070-3","volume":"49","author":"M Akimoto","year":"2000","unstructured":"Akimoto M, Nagahata N, Furuya A, Fukushima K, Higuchi S, Suwa T. Gastric pH profiles of beagle dogs and their use as an alternative to human testing. Eur J Pharm Biopharm. 2000;49(2):99\u2013102.","journal-title":"Eur J Pharm Biopharm"},{"key":"4219_CR15","unstructured":"FDA. Safety testing of drug metabolites guidance for industry. March 2020."},{"key":"4219_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.yrtph.2018.12.007","volume":"102","author":"A Amberg","year":"2019","unstructured":"Amberg A, Andaya RV, Anger LT, Barber C, Beilke L, Bercu J, et al. Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses. Regul Toxicol Pharmacol. 2019;102:53\u201364.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"12","key":"4219_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103366","volume":"27","author":"P Agarwal","year":"2022","unstructured":"Agarwal P, Huckle J, Newman J, Reid DL. Trends in small molecule drug properties: a developability molecule assessment perspective. Drug Discov Today. 2022;27(12):103366.","journal-title":"Drug Discov Today"},{"issue":"2","key":"4219_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1021\/acs.oprd.4c00320","volume":"29","author":"DL Reid","year":"2025","unstructured":"Reid DL, Faul MM, L\u00f3pez-Mej\u00edas V, Agarwal P, Bergauer M, Blue LE, et al. Application of an Interdisciplinary Approach to Form Selection in Drug Development. Org Process Res Dev. 2025;29(2):237\u201354.","journal-title":"Org Process Res Dev"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04219-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04219-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04219-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:02:04Z","timestamp":1792825324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04219-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":18,"alternative-id":["4219"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04219-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"1 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing financial interest(s): All authors are current or former employees of Amgen, Inc. and may hold stock in the same. All studies were funded by Amgen, Inc.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}